Literature DB >> 24380802

Expression and purification of soluble HIV-2 viral protein R (Vpr) using a sandwich-fusion protein strategy.

Karen Hänel1, Luis Möckel1, Monika Brummel2, Katja Peiris2, Rudolf Hartmann1, Andrew J Dingley1, Dieter Willbold3, Angelika Loidl-Stahlhofen2.   

Abstract

Viral accessory proteins of the human immunodeficiency virus (HIV), including virus protein R (Vpr), are crucial for the efficient replication of the virus in the host organism. While functional data are available for HIV-1 Vpr, there is a paucity of data describing the function and structure of HIV-2 Vpr. In this report, the construction of a His6-MBP-intein1-Vpr-intein2-Cyt b5-His6 fusion protein is presented. Unlike previous research efforts where only microgram quantities of HIV-1 Vpr could be produced, this construct enabled soluble milligram yields via an Escherichia coli over-expression system. Straightforward protein purification of HIV-2 Vpr was achieved by standard chromatography routines and autocatalytic intein cleavage. Preliminary structural studies by circular dichroism (CD) and NMR spectroscopy revealed that the protein is stable in the presence of micellar concentrations of the detergent DPC and adopts an α-helix secondary structure.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  DPC; HIV accessory proteins; HIV-2 Vpr; Intein; NMR; Sandwich fusion protein

Mesh:

Substances:

Year:  2013        PMID: 24380802     DOI: 10.1016/j.pep.2013.12.007

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  2 in total

1.  Inhibitory Effects of HIV-2 Vpx on Replication of HIV-1.

Authors:  Mohamed Mahdi; Zsófia Szojka; János András Mótyán; József Tőzsér
Journal:  J Virol       Date:  2018-06-29       Impact factor: 5.103

2.  Impact of HIV-1 Vpr manipulation of the DNA repair enzyme UNG2 on B lymphocyte class switch recombination.

Authors:  Patrick Eldin; Sophie Péron; Anastasia Galashevskaya; Nicolas Denis-Lagache; Michel Cogné; Geir Slupphaug; Laurence Briant
Journal:  J Transl Med       Date:  2020-08-10       Impact factor: 5.531

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.